Lyell completes $65M cell therapy manufacturing facility

By The Science Advisory Board staff writers

March 23, 2021 -- Lyell Immunopharma has completed its $65 million Lyfe Manufacturing Center in Bothell, WA. The facility will be used to produce cell products for upcoming clinical trials.

Lyell is combining its proprietary ex vivo genetic and epigenetic reprogramming technologies to develop T-cell receptors, tumor-infiltrating lymphocytes, and chimeric antigen receptor-based cell therapies.

The 70,000-sq-ft production facilities house advanced capabilities for cell therapy manufacturing. In addition to cell processing equipment and manufacturing processes necessary to expand and reengineer patient immune cells, the center will integrate advanced data and analytics approaches that enable a completely digital manufacturing process. This includes real-time data feedback and batch monitoring, as well as analytical capabilities that enable artificial intelligence and machine-learning applications to enable faster process improvements.

Lyell's Lyfe center is the first cell therapy manufacturing facility to support digital manufacturing capabilities from Amazon Web Services, including cloud computing, Internet of Things (IoT), and advanced analytics.

MilliporeSigma boosts capacity at French assembly facility
MilliporeSigma is adding a single-use assembly production unit to its facility in Molsheim, France.
Cytovia ramps up production of NK cells ahead of trials
Cytovia Therapeutics has signed two agreements for research and development and manufacturing operations to move the company's chimeric antigen receptor-natural...
Fujifilm picks Holly Springs for new facility
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization for biologics, viral vaccines, and gene therapies, announced...
Arranta Bio adds new manufacturing facility
Arranta Bio is adding a 130,000-sq-ft facility in Boxborough, MA, to complement its facilities in Watertown, MA, and Gainesville, FL, bringing its total...
Resilience expands U.S. biologics manufacturing footprint
Resilience is building its North American presence for biologics manufacturing through the acquisition of two commercial manufacturing facilities, one...

Copyright © 2021

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter